IL132293A0 - Use of lactoferin in the treatment of allergen induced disorders - Google Patents

Use of lactoferin in the treatment of allergen induced disorders

Info

Publication number
IL132293A0
IL132293A0 IL13229398A IL13229398A IL132293A0 IL 132293 A0 IL132293 A0 IL 132293A0 IL 13229398 A IL13229398 A IL 13229398A IL 13229398 A IL13229398 A IL 13229398A IL 132293 A0 IL132293 A0 IL 132293A0
Authority
IL
Israel
Prior art keywords
lactoferin
treatment
induced disorders
allergen induced
allergen
Prior art date
Application number
IL13229398A
Other languages
English (en)
Original Assignee
Agennix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agennix Inc filed Critical Agennix Inc
Publication of IL132293A0 publication Critical patent/IL132293A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL13229398A 1997-04-10 1998-04-10 Use of lactoferin in the treatment of allergen induced disorders IL132293A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4189097P 1997-04-10 1997-04-10
PCT/US1998/007234 WO1998044940A1 (fr) 1997-04-10 1998-04-10 Utilisation de la lactoferrine dans le traitement des troubles induits par allergenes

Publications (1)

Publication Number Publication Date
IL132293A0 true IL132293A0 (en) 2001-03-19

Family

ID=21918897

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13229398A IL132293A0 (en) 1997-04-10 1998-04-10 Use of lactoferin in the treatment of allergen induced disorders

Country Status (12)

Country Link
US (1) US20030190303A1 (fr)
EP (1) EP0979099B1 (fr)
JP (1) JP2001519815A (fr)
CN (1) CN1262625A (fr)
AT (1) ATE297755T1 (fr)
AU (1) AU747385C (fr)
CA (1) CA2285960A1 (fr)
DE (1) DE69830582T2 (fr)
ES (1) ES2245028T3 (fr)
IL (1) IL132293A0 (fr)
NZ (1) NZ500712A (fr)
WO (1) WO1998044940A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL336626A1 (en) * 1997-05-03 2000-07-03 Regents Board Of Methods of preventing and treating traumatic loss of metabolic equlibrium among human beings and animals
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
WO2001051079A1 (fr) * 2000-01-14 2001-07-19 Meiji Dairies Corporation Inhibiteurs de production d'anticorps ige specifique d'un antigene
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
US7364736B2 (en) 2001-06-26 2008-04-29 Amgen Inc. Antibodies to OPGL
CA2471766C (fr) * 2001-12-28 2011-01-11 Nrl Pharma, Inc. Compositions servant a ameliorer le metabolisme lipidique
EP1477182A4 (fr) 2002-01-21 2009-05-27 Nrl Pharma Inc Nouveaux analgesiques
JP4685443B2 (ja) * 2002-05-10 2011-05-18 エイジェニックス・インコーポレイテッド 悪性新生物および他の過剰増殖性疾患の治療におけるラクトフェリン
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
TWI289668B (en) 2002-09-06 2007-11-11 Amgen Inc Therapeutic human anti-IL-1R1 monoclonal antibody
DK1545587T3 (da) * 2002-09-16 2011-05-09 Agennix Inc Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
AU2003298906A1 (en) * 2002-12-06 2004-06-30 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
AU2003296447A1 (en) 2002-12-10 2004-06-30 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
AU2004289170B2 (en) * 2003-06-06 2009-12-17 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
AU2005252436B2 (en) * 2004-06-11 2010-11-11 The University Of Manchester Method for ameliorating an inflammatory skin condition
WO2006047744A2 (fr) 2004-10-26 2006-05-04 Agennix Incorporated Compositions de peptides en rapport avec la lactoferrine et utilisations
DK1833495T3 (da) * 2005-03-15 2008-06-02 Campina Nederland Holding Bv Dermatologisk anvendelse af mælkeproteiner
US8178486B2 (en) * 2005-07-21 2012-05-15 Animal Technology Institute Taiwan Method for promoting hair growth
WO2007043900A1 (fr) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Utilisation de fragments de lactoferrine et d'hydrolysats
JPWO2007049757A1 (ja) * 2005-10-27 2009-04-30 サンスター株式会社 ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤
CN105412912A (zh) * 2010-04-23 2016-03-23 普若拜特有限公司 湿疹治疗
CN102370964B (zh) * 2010-08-16 2015-12-09 李兴德 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
EP3836954A1 (fr) 2018-08-13 2021-06-23 Iltoo Pharma Combinaison d'interleukine 2 et d'un inhibiteur de l'interleukine 1, conjugués et utilisations thérapeutiques de celle-ci
EP4072322A1 (fr) * 2019-12-11 2022-10-19 N.V. Nutricia Composition nutritionnelle pour améliorer la résistance immunitaire
WO2023222565A1 (fr) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Procédés d'évaluation de l'épuisement de cellules souches hématopoïétiques induites par une inflammation chronique
CN115737787B (zh) * 2022-12-15 2024-04-19 四川大学 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2596986B1 (fr) * 1986-04-11 1988-09-23 Sederma Sa Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres
FR2641696B2 (fr) * 1986-04-11 1991-03-08 Sederma Sa Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres
FR2685202B1 (fr) * 1991-12-24 1995-03-24 Sederma Sa Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee.
JP3184923B2 (ja) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア 抗リウマチ剤
JPH05279266A (ja) * 1992-04-02 1993-10-26 Imuno Japan:Kk 歯周病の治療・予防用医薬組成物
JP3163171B2 (ja) * 1992-07-15 2001-05-08 森永乳業株式会社 ＩｇＡ産生促進剤
JP3746081B2 (ja) * 1994-02-24 2006-02-15 森永乳業株式会社 動物皮膚病治療剤
JPH0859450A (ja) * 1994-08-18 1996-03-05 Kose Corp 皮膚外用剤
JP2832517B2 (ja) * 1994-12-09 1998-12-09 雪印乳業株式会社 大腸菌付着阻止剤
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
JP3888707B2 (ja) * 1996-01-22 2007-03-07 森永乳業株式会社 血管新生病治療剤
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof

Also Published As

Publication number Publication date
CA2285960A1 (fr) 1998-10-15
CN1262625A (zh) 2000-08-09
US20030190303A1 (en) 2003-10-09
ATE297755T1 (de) 2005-07-15
NZ500712A (en) 2002-10-25
AU6964798A (en) 1998-10-30
EP0979099A1 (fr) 2000-02-16
JP2001519815A (ja) 2001-10-23
AU747385B2 (en) 2002-05-16
DE69830582D1 (de) 2005-07-21
AU747385C (en) 2003-01-30
DE69830582T2 (de) 2006-05-04
WO1998044940A1 (fr) 1998-10-15
ES2245028T3 (es) 2005-12-16
EP0979099B1 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
IL132293A0 (en) Use of lactoferin in the treatment of allergen induced disorders
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
KR100521829B1 (en) Compositions and Methods for the Treatment of Alzheimer's Disease, Central Nervous System Injury, and Inflammatory Diseases
BR0007556A (pt) Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
WO2003099195A3 (fr) Composes immunomodulateurs et methodes d'utilisation de ces composes
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
IL115733A0 (en) Binding agents and their use for therapeutic treatment
HK1026144A1 (en) Aryl ureas for the treatment of inflammatory or immunomodulatory diseases.
DE69316948D1 (de) Lösliche Liganden für CD40
BG103646A (en) Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases
EP1005345A4 (fr) Procede et compositions destines au traitement d'asthme allergique et d'autres affections au moyen de descarboethoxyloratadine
GB0111186D0 (en) Novel compounds
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
PT1463735E (pt) Imidazo-2,1-b-1,3,4-tiadiazol sulfonamidas
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
BR0010560A (pt) 3-piridil-4-arilpirrois substituìdos e métodos terapêuticos e profiláticos relacionados
MD1140B1 (en) Remedy possessing a regenerative and cytoprotective activity
WO1998036758A3 (fr) Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
MY129421A (en) INHIBITORS OF p38
MX9606304A (es) Benzopiranos y uso como agentes terapeuticos.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees